Overview

Xylometazoline and Cocaine for Nasal Vasoconstriction

Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare xylometazoline and cocaine's effect on minimizing epistaxis when administered as a local vasoconstrictor prior to nasal intubation. We hypothesize that there will be a lower bleeding score in the group receiving xylometazoline as compared with the group receiving cocaine.
Phase:
Phase 4
Details
Lead Sponsor:
Rigshospitalet, Denmark
Treatments:
Cocaine
Xylometazoline